ZURICH/BERLIN, Nov 9 (Reuters) – Here are some of the main factors that may affect Swiss stocks on Friday:
Novartis NOVN.S said on Thursday its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug.
Novartis also reported it has acquired a 20.7 percent stake in Gamida Cell as of Oct 26.
H1 2018/2019 results due. Net profit seen up 6.1 percent.
CEO Frankie Ng is due to outline lowered targets that the company said were needed after a downturn in commodities markets.
The U.S. government filed a civil fraud lawsuit accusing UBS of defrauding investors in its sale of residential mortgage-backed securities leading up to the 2008-09 global financial crisis.
SNB Governing Board Member Andrea Maechler said it would be premature for the Swiss National Bank to consider tightening monetary policy even a decade after the outbreak of the global financial crisis. (Reporting by Zurich newsroom and Berlin Speed Desk)